DIPLACUSIS

This adverse event was reported 21 times

These drugs are most commonly taken by patients reporting DIPLACUSIS:

# Drug Count
0 SILDENAFIL CITRATE 9
1 SILDENAFIL 8
2 SILDENAFIL POWDER, 5
3 AMBRISENTAN 2
4 AZITHROMYCIN 2
5 AZITHROMYCIN DIHYDRATE 2
6 AZITHROMYCIN MONOHYDRATE 2
7 0XYGEN 1
8 ADALIMUMAB 1
9 AMIKACIN 1
See all common drugs associated with DIPLACUSIS

DIPLACUSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CANAGLIFLOZIN AND METFORMIN HYDROCHLORIDE 1 0.0006
1 NEOMYCIN OINTMENT 1 0.0004
2 LEVALBUTEROL HYDROCHLORIDE 1 0.0003
3 SILDENAFIL POWDER, 5 0.0001
4 MICONAZOLE NITRATE 1 0.0001
5 SILDENAFIL CITRATE 9 0.0001
6 RIFAMPIN 1 0.0001
7 AMIKACIN 1 0.0001
8 RIVASTIGMINE 1 0.0001
9 ERYTHROPOIETIN 1 0.0000
See all drugs enriched for association with DIPLACUSIS

DIPLACUSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Cholinesterase Inhibitor [EPC] 1 0.0001
1 Phosphodiesterase 5 Inhibitor [EPC] 5 0.0000
2 Rifamycin Antibacterial [EPC] 1 0.0000
3 Aminoglycoside Antibacterial [EPC] 1 0.0000
4 Insulin [EPC] 1 0.0000
5 Folate Analog [EPC] 1 0.0000
6 Vitamin A [EPC] 1 0.0000
7 Peroxisome Proliferator Receptor alpha Agonist [EPC] 1 0.0000
8 Nicotinic Acid [EPC] 1 0.0000
9 Antidote [EPC] 1 0.0000
See all drug classes enriched for association with DIPLACUSIS